Tucker Asset Management’s GSK GSK Stock Holding History

Tucker Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-613	Closed	-$30.1K	–	651
2025 Q4	$30.1K	Buy	+613	New	+$28.6K	0.01%	394
2025 Q1	–	Sell	-88	Closed	-$2.98K	–	575
2024 Q4	$2.98K	Buy	88 +17	+24%	+$612	﹤0.01%	1124
2024 Q3	$2.9K	Sell	71 -84	-54%	-$3.44K	﹤0.01%	1079
2024 Q2	$5.97K	Hold	155	–	–	﹤0.01%	994
2024 Q1	$6.64K	Hold	155	–	–	﹤0.01%	990
2023 Q4	$5.74K	Sell	155 -4	-3%	-$144	﹤0.01%	855
2023 Q3	$5.76K	Hold	159	–	–	﹤0.01%	791
2023 Q2	$5.67K	Hold	159	–	–	﹤0.01%	650
2023 Q1	$5.66K	Hold	159	–	–	﹤0.01%	677
2022 Q4	$5.59K	Hold	159	–	–	﹤0.01%	427
2022 Q3	$5.27K	Buy	159 +75	+89%	+$2.84K	﹤0.01%	420
2022 Q2	$4.57K	Buy	+84	New	+$4.64K	﹤0.01%	351
2021 Q3	–	Sell	-134	Closed	-$6.69K	–	391
2021 Q2	$6.69K	Buy	+134	New	+$6.44K	﹤0.01%	207
2021 Q1	–	Sell	-134	Closed	-$6.18K	–	358
2020 Q4	$6.18K	Buy	+134	New	+$6.16K	﹤0.01%	224

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Tucker Asset Management's GSK Position: Q1 2026 in Review

Tucker Asset Management sold out of GSK (GSK) in Q1 2026, closing a stake of 613 shares — an estimated $30.1K sold.

Tucker Asset Management first reported a position in GSK in Q4 2020 and held it in 14 quarters. The position peaked at $30.1K in Q4 2025. 1,036 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Tucker Asset Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Tucker Asset Management sold 613 GSK shares in Q1 2026, an estimated $30.1K.
Tucker Asset Management first reported a position in GSK in Q4 2020 and held it in 14 quarters.
Tucker Asset Management's GSK position peaked at $30.1K in Q4 2025.
1,036 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.